D. Alemayehu

发表

Statistical Topics in Health Economics and Outcomes Research

J. Cappelleri, B. Emir, D. Alemayehu, 2017 .

Statistical Issues with the Analysis of Nonrandomized Studies in Comparative Effectiveness Research

R. Willke, B. Jones, J. Alvir, 2011, Journal of managed care pharmacy : JMCP.

Vaccines: A review of immune‐based interventions to prevent and treat disease

C. Knirsch, D. Alemayehu, E. Utt, 2015, Journal of clinical pharmacology.

Infrastructure Requirements for Secondary Data Sources in Comparative Effectiveness Research

J. Mardekian, D. Alemayehu, 2011, Journal of managed care pharmacy : JMCP.

Evaluation of Reporting Bias in Postmarketing Risk Assessment Based on Spontaneous Reporting Systems

D. Alemayehu, 2009, Pharmaceutical Medicine.

Streamlining Safety Data Collection in Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia Trials: Recommendations of the Clinical Trials Transformation Initiative Antibacterial Drug Development Project Team.

R. Wunderink, C. Knirsch, H. Donnelly, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Toward a Pragmatic Policy on Authorship

D. Alemayehu, Marcia Levenstein, 2011 .

Patient-Reported Outcomes: Measurement, Implementation and Interpretation

K. Zou, J. Cappelleri, T. Symonds, 2013 .

Examination of Data, Analytical Issues and Proposed Methods for Conducting Comparative Effectiveness Research Using “Real-World Data”

E. Perfetto, R. Willke, P. Subedi, 2011, Journal of Managed Care Pharmacy : JMCP.

Table of Contents Examination of Data , Analytical Issues and Proposed Methods for Conducting Comparative Effectiveness Research Using “ Real-World Data ”

E. Perfetto, R. Willke, P. Subedi, 2011 .

Considerations for the Design and Conduct of a Pharmacovigilance Study Involving Mass Drug Administration in a Resource-Constrained Setting

C. Knirsch, P. Glue, D. Alemayehu, 2010, PLoS neglected tropical diseases.

Assessing exchangeability in indirect and mixed treatment comparisons

D. Alemayehu, 2011 .

A paradigm shift in drug development for treatment of rare multidrug-resistant gram-negative pathogens.

C. Knirsch, J. Quinn, D. Alemayehu, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Emerging Topics

B. Emir, D. Alemayehu, M. Gaffney, 2020, Interface between Regulation and Statistics in Drug Development.

Considerations on the Use of Patient-Reported Outcomes in Comparative Effectiveness Research

Joseph C Cappelleri, Demissie Alemayehu, Robert J Sanchez, 2011, Journal of managed care pharmacy : JMCP.

On the bias and variance of odds ratio, relative risk and false discovery proportion

Guodong Pang, Demissie Alemayehu, Michael J. Klass, 2021, Communications in Statistics - Theory and Methods.

Improving Conduct and Feasibility of Clinical Trials to Evaluate Antibacterial Drugs to Treat Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia: Recommendations of the Clinical Trials Transformation Initiative Antibacterial Drug Development Project Team.

V. Fowler, G. Noel, C. Knirsch, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Perspectives on Pooled Data Analysis: the Case for an Integrated Approach

Demissie Alemayehu, D. Alemayehu, 2021 .

Current Issues with Covariate Adjustment in the Analysis of Data from Randomized Controlled Trials

D. Alemayehu, 2011, American journal of therapeutics.

Applications of ROC analysis in medical research: recent developments and future directions.

Demissie Alemayehu, Kelly H Zou, K. Zou, 2012, Academic radiology.

Borrowing Concurrent Information from Non-Concurrent Control to Enhance Statistical Efficiency in Platform Trials

D. Alemayehu, L. Nie, Chengxing Lu, 2023, Current oncology.

Evaluating methodological assumptions in comparative effectiveness research: overcoming pitfalls.

J. Cappelleri, D. Alemayehu, 2014, Journal of comparative effectiveness research.

A causal roadmap for generating high-quality real-world evidence

Raymond A. Huml, E. Stuart, Emre Kıcıman, 2023, Journal of Clinical and Translational Science.

Conceptual and Analytical Considerations toward the Use of Patient-Reported Outcomes in Personalized Medicine.

J. Cappelleri, D. Alemayehu, 2012, American health & drug benefits.

A comparative study of subgroup identification methods for differential treatment effect: Performance metrics and recommendations

Marianthi Markatou, Yang Chen, Demissie Alemayehu, 2018, Statistical methods in medical research.

Tests for Normality Based on Entropy Divergences

Jiqiang Guo, Demissie Alemayehu, Jiqiang Guo, 2010 .

Prediction and estimation of random variables with infinite mean or variance

H. Gzyl, D. Alemayehu, Silvia Mayoral, 2023, 2303.14752.

Multiarmed Bandit Designs for Phase I Dose-Finding Clinical Trials With Multiple Toxicity Types

G. Pang, D. Alemayehu, Lan Jin, 2021, Statistics in Biopharmaceutical Research.

Big Data: transforming drug development and health policy decision making

Demissie Alemayehu, Marc L Berger, M. Berger, 2016, Health Services and Outcomes Research Methodology.

Finite Mixture Models, a Flexible Alternative to Standard Modeling Techniques for Extrapolated Mean Survival Times Needed for Cost-Effectiveness Analyses.

Demissie Alemayehu, Birol Emir, Paul R Cislo, 2021, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Perspectives on Virtual (Remote) Clinical Trials as the “New Normal” to Accelerate Drug Development

Satrajit Roychoudhury, R. Hemmings, D. Alemayehu, 2021, Clinical pharmacology and therapeutics.

Revisiting issues, drawbacks and opportunities with observational studies in comparative effectiveness research.

J. Cappelleri, D. Alemayehu, 2013, Journal of evaluation in clinical practice.

A New Paradigm for Deriving and Analyzing Number Needed to Treat

D. Alemayehu, Ed Whalen, 2006, Journal of biopharmaceutical statistics.

Methodological Considerations in Cost-Effectiveness Analysis

D. Alemayehu, 2014 .

Methodological Considerations in Cost-Effectiveness Analysis Demissie Alemayehu

D. Alemayehu, 2014 .

Perspectives on clinical trial data transparency and disclosure.

R. Anziano, D. Alemayehu, Marcia Levenstein, 2014, Contemporary clinical trials.

STATISTICAL CONSIDERATIONS FOR CLINICAL TRIALS IN RARE DISEASES

C. Knirsch, D. Alemayehu, Marcia Levenstein, 2014 .

Using the bootstrap in correlation analysis, with application to a longitudinal data set

K. Doksum, D. Alemayehu, 1990 .

Bootstrapping the latent roots of certain random matrices

Demissie Alemayehu, D. Alemayehu, 1988 .

A comparative study of subgroup identification methods for differential treatment effect: Performance metrics and recommendations

M. Markatou, Y. Chen, D. Alemayehu, 2018, Statistical methods in medical research.

Evaluation of Heterogeneity of Treatment Effects in Comparative Effectiveness Research

D. Alemayehu, 2011 .

Bootstrap Inference Relating to Pr[X < Y]

D. Alemayehu, 1992 .